Abstract
Antiviral activity of TiO2 · PL · DNA/PNA nanobiocomposites was studied on the MDCK cell culture infected with influenza A virus (H3N2 subtype). A PNA fragment in nanocomposites was electrostatically bound in the form of a DNA/PNA heteroduplex to titanium dioxide nanoparticles precovered with polylysine (TiO2 · PL). It was shown that TiO2 · PL · DNA1/PNA1 nanobiocomposite bearing the PNA1 fragment targeted to the 3′-end of the noncoding region of segment 5 of viral RNA specifically inhibited the virus reproduction with an efficiency of 99.8%. The 50% cytotoxic concentration (TC50) and 50% effective inhibitory concentration (IC50) of the TiO2 · PL · DNA1/PNA1 nanocomposite were evaluated to be more than 1200 μg/mL and less than 3 μg/mL, respectively. Based on these data, the selectivity index (SI) for TiO2 · PL · DNA1/PNA1 nanobiocomposite defined as the TC50/IC50 ratio, was calculated to be more than 400. Thus, TiO2 · PL · DNA/PNA nanobiocomposites were shown to not only penetrate through cell membranes, but exhibit a high specific antisense activity without toxic effects on the living cells.
Similar content being viewed by others
Abbreviations
- TC50 :
-
50% cytotoxic concentration
- IC50 :
-
50% effective concentration
- NI:
-
neutralization index as the difference of logarithms of the virus titer in the absence (control) and the presence (sample) of the nanocomposites
- PL:
-
poly-L-lysine
- SI:
-
selectivity index as the ratio of TC50 to IC50
- vRNA:
-
viral RNA
- mRNA:
-
messenger RNA complementary to vRNA
- cRNA:
-
replication copy of vRNA
- PNA:
-
peptide nucleic acid
References
Amirkhanov, R.N., Zarytova, V.F., Amirkhanov, N.V., Russ. J. Bioorg. Chem., 2014, vol. 40, pp. 263–268.
Zamecnik, P. and Stephenson, M., Proc. Natl. Acad. Sci. U.S.A., 1978, vol. 75, pp. 280–284.
Summerton, J., J. Theor. Biol., 1979, vol. 78, pp. 77–99.
Summerton, J. and Weller, D., Antisense Nucleic Acid Drug Dev., 1997, vol. 7, pp. 187–195.
Nielsen, P.E., Peptide Nucleic Acids: Protocols and Applications, Wymondam; United Kingdom: Horizon Bioscience, 2004.
Moulton, H.M., Nelson, M.H., Hatlevig, S.A., Reddy, M.T., and Iversen, P.L., Bioconjug. Chem., 2004, vol. 15, pp. 290–299.
Ge, Q., Pastey, M., Kobasa, D., Puthavathana, P., Lupfer, C., Bestwick, R.K., Iversen, P.L., Chen, J., and Stein, D.A., Antimicrob. Agents Chemother., 2006, vol. 50, pp. 3724–3733.
Leiter, J.M., Agrawal, S., Palese, P., and Zamecnik, P.C., Proc. Natl. Acad. Sci. U.S.A., 1990, vol. 87, pp. 3430–3434.
Bendifallah, N., Rasmussen, F.W., Zachar, V., Ebbesen, P., Nielsen, P.E., and Koppelhus, U., Bioconjug. Chem., 2006, pp. 750–758.
McManus, M.T. and Sharp, P.A., Nat. Rev. Genet., 2002, vol. 3, pp. 737–747.
Ge, Q., McManus, M.T., Nguyen, T., Shen, C.H., Sharp, P.A., Eisen, H.N., and Chen, J., Proc. Natl. Acad. Sci. USA, 2003, vol. 100, pp. 2718–2723.
McManus, M.T., Haines, B.B., Dillon, C.P., Whitehurst, C.E., van Parijs, L., Chen, J., and Sharp, P.A., J. Immunol., 2002, vol. 169, pp. 5754–5760.
Demidov, V.V., Potaman, V.N., Frank-Kamenetskii, M.D., Egholm, M., Buchard, O., and Nielsen, P.E., Biochem. Pharmacol., 1994, vol. 48, pp. 1310–1313.
Hamilton, S.E., Iyer, M., Norton, J.C., and Corey, D.R., Bioorg. Med. Chem. Lett., 1996, vol. 6, pp. 2897–2900.
Shiraishi, T. and Nielsen, P.E., Methods in Molecular Biology, 2011, vol. 751, pp. 209–221.
Antsypovich, S.I., Usp. Khim., 2002, vol. 71, no. 1, pp. 81–96.
Koppelhus, U. and Nielsen, P.E., Adv. Drug Deliv. Rev., 2003, vol. 55, pp. 267–280.
Shiraishi, T., Pankratova, S., and Nielsen, P.E., Chem. Biol., 2005, vol. 12, pp. 923–929.
Amirkhanov, N.V., Amirkhanov, R.N., Zarytova, V.F., Rus. J. Bioorg. Chem., 2012, vol. 38, pp. 613–624.
Amirkhanov, R.N., Zarytova, V.F., and Amirkhanov, N.V., Russ. J. Bioorg. Chem., 2013, vol. 39, pp. 629–638.
Kaverin, N.V., Mol. Biol., 1980, vol. 14, pp. 245–260.
Lamb, R.A. and Krug, R.M., in Fundamental Virology, Knipe, D.M. and Howely, P.M, Eds., Philadelphia: Lippincott Williams and Wilkins, 2001, pp. 725–770.
Levina, A.S., Repkova, M.N., Ismagilov, Z.R., Shikina, N.V., Mazurkova, N.A., and Zarytova, V.F., Russ. J. Bioorg. Chem., 2014, vol. 40, pp. 196–202.
Portela, A. and Digard, P., J. Gen. Virol., 2002, vol. 83, pp. 723–734.
Rajh, T., Saponjic, Z., Liu, J., Dimitrijevic, N.M., Scherer, N.F., Vega-Arroyo, M., Zapol, P., Curtiss, L.A., and Thurnauer, M.C., Nano Letters, 2004, vol. 4, pp. 1017–1023.
Richards, E., in Handbook of Biochemistry and Molecular Biology: Nucleic Acids, Fasman, G.D., Ed., Cleveland: CRC Press, 1975, vol. 1.
Osano, E., Kishi, J., and Takahashi, Y., Toxicol. in vitro, 2003, vol. 17, pp. 41–47.
Author information
Authors and Affiliations
Corresponding author
Additional information
Original Russian Text © R.N. Amirkhanov, N.A. Mazurkova, N.V. Amirkhanov, V.F. Zarytova, 2015, published in Bioorganicheskaya Khimiya, 2015, Vol. 41, No. 2, pp. 162–169.
Report III in [1].
Rights and permissions
About this article
Cite this article
Amirkhanov, R.N., Mazurkova, N.A., Amirkhanov, N.V. et al. Composites of peptide nucleic acids with titanium dioxide nanoparticles. IV. Antiviral activity of nanocomposites containing DNA/PNA duplexes. Russ J Bioorg Chem 41, 140–146 (2015). https://doi.org/10.1134/S1068162015020028
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S1068162015020028